| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2017PLoSO..1278027R |
| P356 | DOI | 10.1371/JOURNAL.PONE.0178027 |
| P932 | PMC publication ID | 5479524 |
| P698 | PubMed publication ID | 28636636 |
| P50 | author | Milo Frattini | Q95979739 |
| Stephen Hamilton-Dutoit | Q42323196 | ||
| P2093 | author name string | Alice Riva | |
| Elisabetta Merlo | |||
| Christina Andersen | |||
| Jan Lorenzen | |||
| Samantha Epistolio | |||
| Kirsten Voogd | |||
| Majbritt Hauge Kyneb | |||
| Mariann Guldmann-Christensen | |||
| Michael BØrgesen | |||
| Tine Yding Wolff | |||
| Ulf Bech Christensen | |||
| P2860 | cites work | RAS oncogenes: the first 30 years. | Q55036584 |
| Intercalating Nucleic Acids: The Influence of Linker Length and Intercalator Type on Their Duplex Stabilities | Q63761354 | ||
| A method to detect ras point mutations in small subpopulations of cells | Q68314888 | ||
| p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer | Q78632829 | ||
| Epidermal growth factor receptor-targeted therapy in colorectal cancer | Q86982951 | ||
| Molecular Subtypes and Personalized Therapy in Metastatic Colorectal Cancer | Q26747329 | ||
| Insight to drug delivery aspects for colorectal cancer | Q26774682 | ||
| Molecular phenotypes of colorectal cancer and potential clinical applications | Q26785725 | ||
| Quantitative and sensitive detection of rare mutations using droplet-based microfluidics | Q28238121 | ||
| The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers | Q29395525 | ||
| Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications | Q33947050 | ||
| Ras and Rho GTPases: a family reunion | Q34073399 | ||
| Estimates of cancer incidence and mortality in Europe in 2008. | Q34095813 | ||
| Intercalating nucleic acids containing insertions of 1-O-(1-pyrenylmethyl)glycerol: stabilisation of dsDNA and discrimination of DNA over RNA. | Q34369300 | ||
| Validation of a next-generation-sequencing cancer panel for use in the clinical laboratory. | Q35377839 | ||
| Validation of targeted next-generation sequencing for RAS mutation detection in FFPE colorectal cancer tissues: comparison with Sanger sequencing and ARMS-Scorpion real-time PCR. | Q36472281 | ||
| A comparison of Direct sequencing, Pyrosequencing, High resolution melting analysis, TheraScreen DxS, and the K-ras StripAssay for detecting KRAS mutations in non small cell lung carcinomas | Q36523724 | ||
| KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program. | Q37273361 | ||
| Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer | Q37274280 | ||
| Important molecular genetic markers of colorectal cancer. | Q37619856 | ||
| 454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples. | Q38395259 | ||
| Spectrum of Gene Mutations in Colorectal Cancer: Implications for Treatment | Q38876058 | ||
| Mutation spectra of RAS gene family in colorectal cancer | Q38890904 | ||
| Improving the limit of detection for Sanger sequencing: A comparison of methodologies for KRAS variant detection | Q39256278 | ||
| Clinical relevance of KRAS-mutated subclones detected with picodroplet digital PCR in advanced colorectal cancer treated with anti-EGFR therapy | Q40224084 | ||
| Recurrent KRAS codon 146 mutations in human colorectal cancer | Q40232898 | ||
| Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR. | Q41199696 | ||
| Rapid and sensitive nonradioactive detection of mutant K-ras genes via 'enriched' PCR amplification | Q41682735 | ||
| Different types of K-Ras mutations are conversely associated with overall survival in patients with colorectal cancer. | Q45908649 | ||
| PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancer. | Q46034442 | ||
| Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines | Q46937946 | ||
| APC mutations and other genetic and epigenetic changes in colon cancer. | Q54446969 | ||
| Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer. | Q54585853 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | screen time | Q28130149 |
| P304 | page(s) | e0178027 | |
| P577 | publication date | 2017-06-21 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | SensiScreen®KRAS exon 2-sensitive simplex and multiplex real-time PCR-based assays for detection of KRAS exon 2 mutations | |
| P478 | volume | 12 |
| Q64055558 | Application of lab-on-a-chip multiplex cassette PCR for the detection of enterohemorrhagic Escherichia coli | cites work | P2860 |
Search more.